ID Name Structure References (top 5) Molecular Target(s)
1ID:6728
XANTHOTOXIN


NSC#:45923
Aldrich#:232726
Aldrich#:95560
Aldrich#:M3501
FDA approved!!!

Freqency:
in 4 ingredients:

  • 85
  • 100
  • 182
  • 454
  • in 33 recipes:

  • 1
  • 22
  • 51
  • 55
  • 61
  • 62
  • 63
  • 73
  • 77
  • 97
  • 112
  • 158
  • 161
  • 162
  • 168
  • 187
  • 193
  • 203
  • 229
  • 292
  • 299
  • 301
  • 303
  • 309
  • 310
  • 313
  • 315
  • 377
  • 389
  • 452
  • 456
  • 460
  • 504

  • Properties
    C12H8O4    216.19





    1:  Poot M, Gollahon KA, Emond MJ, Silber JR, Rabinovitch PS.
    Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N-oxide and 8-methoxypsoralen: implications for the disease phenotype.
    FASEB J.    impact factor:   11.88
    2002;  16(7): 757-8

    2:  Oudesluys-Murphy AM, Oudesluys N.
    Tea: not immoral, illegal, or fattening, but is it innocuous?
    Lancet.    impact factor:   10.197
    2002;  360(9336): 878

    3:  Greinix HT, Volc-Platzer B, Kalhs P, Fischer G, Rosenmayr A, Keil F, Honigsmann H, Knobler RM.
    Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.
    Blood.    impact factor:   8.782
    2000;  96(7): 2426-31

    4:  Cohen Y, Dardalhon M, Averbeck D.
    Homologous recombination is essential for RAD51 up-regulation in Saccharomyces cerevisiae following DNA crosslinking damage.
    Nucleic Acids Res.    impact factor:   5.748
    2002;  30(5): 1224-32

    5:  Klosner G, Trautinger F, Knobler R, Neuner P.
    Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response.
    J Invest Dermatol.    impact factor:   4.903
    2001;  116(3): 459-62

     
    Time used: 110 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005